How Life Sciences Manufacturers Can Implement Industry 4.0 Tools

Artificial intelligence is skyrocketing – increasing the speed of work, raising productivity and providing new tools to help manufacturers scale their products safely and efficiently. There are few industries that stand to benefit from this revolution like the life sciences, where patient health and quality of life depends on the speedy delivery of breakthrough vaccines, therapies and cures.

As the world becomes more digital, companies are looking for ways to incorporate tools like artificial intelligence (AI), predictive analytics, and robotics into their daily processes, and the life sciences industry is following suit. In the fourth edition of the Horizons: Life Sciences report, data collected from more than 500 industry professionals reveals that most companies are budgeting for AI, yet remain behind in fully integrating Industry 4.0 technologies.

We are joined on this episode by CRBers Ryan Thompson, Senior Specialist of Industry 4.0; Niranjan Kulkarni, PhD, Senior Director of Consulting; and Peter Walters, Fellow, Advanced Therapies. They address the risks of adopting Industry 4.0 technologies, how those tools can be useful in producing treatments efficiently, and what tools and strategies are worth applying today.

For a deeper dive into the industry’s embrace of Industry 4.0, download your copy of the 2023 Horizons: Life Sciences report.

You can access all the Horizons reports here.

Follow CRB on LinkedIn for all the company’s updates, and visit CRBgroup.com for all the latest insights blogs and company news.